12-03-2018 12:35 PM CET - Health & Medicine
Print

India IVF Services Market Analysis Focusing on Top Key Players – Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd. and others

Press release from: Allied Market Research
India IVF Services Market
India IVF Services Market
India IVF Services Market is projected to reach $829.5 million by 2023, registering a CAGR of 18.2% from 2017 to 2023. Modern lifestyle, increase in infertility rate among couples, and rise in spending of middle class and higher class for IVF treatment are the major factors that boost the growth of the market.

In vitro fertilization (IVF) is an assisted reproductive technology (ART) procedure. It is the process of fertilization, which includes eggs extraction, sperm cell sample retrieval, and then manually combining an egg and sperm in laboratory settings to form an embryo. The embryo(s) is then transferred to the uterus for further gestation.

Download PDF Report Sample @ www.alliedmarketresearch.com/request-sample/2172?utm_sour...

The prominent companies, hospitals, surgical centers, fertility centers, and clinical research institutes profiled in this report include
• Sun Pharmaceuticals Industries Ltd.
• Lab IVF Asia Pte. Ltd.
• LG Life Sciences
• Cadila Pharmaceuticals Ltd.
• Bourn Hall Clinic
• Morpheus Life Sciences Pvt. Ltd.
• Southend Fertility and IVF Centre
• Nova IVI Fertility
• Bloom Fertility Center
• Manipalankur Andrology and Reproductive Medicine
• Cloudnine Hospitals
• Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.) Milann
• Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.).

Other players (profiles not included in the report) in the value chain analysis include, Apollo Hospitals, Fortis Hospitals, Ruby Hall IVF & Endoscopy Center., and others.

The India IVF services market is expected to witness a substantial growth in future owing to rise in incidence of infertility cases, emerging trend of delayed pregnancies among women, and increased occurrences of gamete donations. Furthermore, low cost clinical settings for IVF treatments in India when compared with IVF treatment facilities in the U.S., the UK, and other established markets, rise in popularity of medical and fertility tourism coupled with advanced IVF facilities & treatment options are anticipated to supplement the market growth.

With respect to end users, the fertility clinics segment accounted for about 61% of the India IVF services market revenue in 2016, and is projected to maintain its dominance during the forecast period. In addition, this segment performed 77.4 thousand cycles in 2016, and is projected to reach 245.4 thousand by 2023, growing at a CAGR of 17.9%, thus accounting for the highest number of IVF cycles. This is attributed to the fact that fertility clinics provide technologically advanced and a wide range of fertility treatments under a single roof for patients.

For More Information @ www.alliedmarketresearch.com/purchase-enquiry/2172?utm_so...

Based on cycle type, the fresh IVF cycles segment (non-donor) generated the highest revenue of $187.1 million in 2016, and is expected to reach $606.6 million by 2023, growing at a CAGR of 18.2%. In addition, this segment was the largest segment in the India IVF services market, with 80.1 thousand fresh IVF cycles (non-donor) performed in 2016, and is expected to reach 239.6 thousand cycles by 2023, growing at a CAGR of 16.9% from 2017 to 2023.

Key Findings of the India Ivf Services Market:
• Based on cycle type, in 2016, fresh IVF cycle (non-donor) segment accounted for around 70% share of the total market, in terms of revenue
• Thawed IVF cycle (non-donor) is projected to be the one of the fastest growing segments, registering a CAGR of 19.6% from 2017 to 2023, in terms of revenue
• Based on gender, in 2016, the female infertility segment, in terms of volume, accounted for more than 70% share of the total market.
• Based on IVF procedures, in 2016, non-ICSI IVF accounted for the highest revenue, thereby registering a CAGR of 19.2% from 2017 to 2023.

Access Full Summery @ www.alliedmarketresearch.com/press-release/india-ivf-serv...

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.
News-ID: 1413376 • Views: 161
More releasesMore releases

You can edit or delete your press release here: